The Article deals with the Progressive Neurodegenerative Disease ALS. It includes general background on the pathogenesis, clinical features, genetics and epidemiology. The main goal is to give a comprehensive review of the current available treatment along with the presentation of future developments and strategies from a pharmacotherapuetic point of view.